|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$16.01 |
$16.26 |
$15.32 |
$15.69 |
574.90K | 04/22/2024 |
$15.89 |
$16.10 |
$15.18 |
$15.64 |
437.20K | 04/23/2024 |
$15.67 |
$16.28 |
$15.52 |
$15.90 |
360.20K | 04/24/2024 |
$15.96 |
$16.66 |
$15.60 |
$16.04 |
425.40K | 04/25/2024 |
$15.80 |
$16.16 |
$15.29 |
$16.06 |
604.20K |
|
REGENXBIO is a clinical-stage biotechnology company. Co.'s product candidates include: RGX-314, which is being developed as a gene therapy for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other additional chronic retinal conditions which cause total or partial vision loss for patients in the U.S., Europe and Japan; RGX-121, which is for the treatment of Mucopolysaccharidosis Type II; RGX-111, which is for the treatment of Mucopolysaccharidosis Type I; RGX-181, which is for the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease; and RGX-381, which is for the treatment of ocular manifestations of CLN2 disease. | |
|
REGENXBIO (RGNX) has the following price history information. Looking back at RGNX historical stock prices for the last five trading days, on April 19, 2024, RGNX opened at $16.01, traded as high as $16.26 and as low as $15.32, and closed at $15.69. Trading volume was a total of 574.90K shares. On April 22, 2024, RGNX opened at $15.89, traded as high as $16.10 and as low as $15.18, and closed at $15.64. Trading volume was a total of 437.20K shares. On April 23, 2024, RGNX opened at $15.67, traded as high as $16.28 and as low as $15.52, and closed at $15.90. Trading volume was a total of 360.20K shares. On April 24, 2024, RGNX opened at $15.96, traded as high as $16.66 and as low as $15.60, and closed at $16.04. Trading volume was a total of 425.40K shares. On April 25, 2024, RGNX opened at $15.80, traded as high as $16.16 and as low as $15.29, and closed at $16.06. Trading volume was a total of 604.20K shares.
RGNX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into REGENXBIO shares, starting with a $10,000 purchase of RGNX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/18/2015 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$30.70 |
|
End price/share: |
$16.06 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-47.69% |
|
Average Annual Total Return: |
-7.25% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5,231.56 |
|
Years: |
8.61 |
|
|
|
Date |
Close |
04/19/2024 | $15.69 | 04/22/2024 | $15.64 | 04/23/2024 | $15.90 | 04/24/2024 | $16.04 | 04/25/2024 | $16.06 |
|
|